TSS
NVO

Two Sigma Securities’s Novo Nordisk NVO Stock Holding History

Two Sigma Securities’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,291
Closed -$1.01M – 1853
2025
Q3 		$1.01M Buy
+18,291
New +$1.07M 0.15% 164
2025
Q1 		– Sell
-4,588
Closed -$395K – 1982
2024
Q4 		$395K Sell
4,588
-8,194
-64% -$886K 0.05% 490
2024
Q3 		$1.52M Sell
12,782
-95,844
-88% -$12.8M 0.03% 664
2024
Q2 		$15.5M Buy
108,626
+18,581
+21% +$2.46M 0.19% 116
2024
Q1 		$11.6M Buy
90,045
+81,688
+977% +$9.72M 0.11% 206
2023
Q4 		$865K Sell
8,357
-51,178
-86% -$5.06M 0.01% 1136
2023
Q3 		$5.41M Buy
59,535
+39,249
+193% +$3.46M 0.06% 346
2023
Q2 		$1.64M Buy
20,286
+3,988
+24% +$326K 0.02% 701
2023
Q1 		$1.3M Buy
+16,298
New +$1.16M 0.03% 708
2022
Q4 		– Sell
-4,298
Closed -$214K – 3057
2022
Q3 		$214K Buy
+4,298
New +$230K 0.01% 1891
2022
Q2 		– Sell
-4,922
Closed -$273K – 2663
2022
Q1 		$273K Buy
+4,922
New +$253K 0.01% 1473
2020
Q3 		– Sell
-13,408
Closed -$439K – 1553
2020
Q2 		$439K Buy
+13,408
New +$428K 0.01% 679
2020
Q1 		– Sell
-7,778
Closed -$225K – 2013
2019
Q4 		$225K Sell
7,778
-10,168
-57% -$282K ﹤0.01% 2004
2019
Q3 		$464K Buy
17,946
+5,498
+44% +$139K ﹤0.01% 1258
2019
Q2 		$318K Buy
+12,448
New +$308K ﹤0.01% 1417
2018
Q4 		– Sell
-14,128
Closed -$333K – 2616
2018
Q3 		$333K Buy
14,128
+400
+3% +$9.76K ﹤0.01% 1681
2018
Q2 		$317K Buy
+13,728
New +$326K ﹤0.01% 2023
2017
Q3 		– Sell
-14,806
Closed -$318K – 1134
2017
Q2 		$318K Buy
+14,806
New +$299K 0.06% 336
2017
Q1 		– Sell
-22,578
Closed -$405K – 1048
2016
Q4 		$405K Buy
+22,578
New +$409K 0.14% 188

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Two Sigma Securities's NVO Position: Q4 2025 in Review

Two Sigma Securities sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 18,291 shares — an estimated $1.01M sold.

Two Sigma Securities first reported a position in NVO in Q4 2016 and held it in 19 quarters. The position peaked at $15.5M in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Two Sigma Securities reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 18,291 Novo Nordisk shares in Q4 2025, an estimated $1.01M.
  • Two Sigma Securities first reported a position in Novo Nordisk in Q4 2016 and held it in 19 quarters.
  • Two Sigma Securities's Novo Nordisk position peaked at $15.5M in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.